Log In
BCIQ
Print this Print this
 

Vesneo, Latanoprostene bunod (formerly BOL-303259-X, NCX 116)

Also known as: formerly PF-03187207

  Manage Alerts
Collapse Summary General Information
Company Nicox S.A.
DescriptionNitric oxide (NO)-donating prostaglandin F2-alpha analog
Molecular Target Prostaglandin F (FP) receptor (PTGFR)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$10.0M

$169.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2010

Undisclosed

$10.0M

$169.5M

Get a free BioCentury trial today